Pharma Pulse 4/22/24: Will Synthetic, AI-Based Digital Humans Change Pharma and Life Sciences? Climate Change Increases Rate of Infectious Diseases & more

Will Synthetic, AI-Based Digital Humans Change Pharma and Life Sciences?

Digital twins is an exciting new technology that presents researchers in the life sciences industry with the opportunity to obtain highly detailed sets of data. Abid Rahman, SVP of innovation at EVERSANA, spoke with Pharmaceutical Executive about the new technology and how it can be used.

Climate Change Increases Rate of Infectious Diseases, Expert Says

Speaker Monica Diaz describes the detrimental impact climate change has on the transmission and increases in infectious disease cases.

The Smartest Way to Use AI at Work

Generative AI tools can help you get ahead in the office—if you know how to use them.

US FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO®(vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease

ENTYVIO is now available in the US in both IV and subcutaneous administrations for maintenance treatment of adults with moderately to severely active ulcerative colitis or Crohn’s Disease.

Antonio Bebba on LinkedIn:

To quote Edward Deming, 85% of the reasons for failure to meet customers’ or (in our case) patients’ expectations are related to deficiencies in systems and processes which actually are built by people. This is the reason why excellence, innovation and efficiency are key and a fundamental part of the conversation.

The 2024 Logipharma conference has been highly focused on how diversity and people can drive innovative solutions in the future Supply chain, so I was delighted to be included, along with Beatrice Colombo and other Pfizer leaders present at the event, and to have an opportunity to contribute to the conversation.

A big thank you to all the business leaders who are growing their understanding of the importance of better leveraging people and diversity rather than processes to find better ways to meet our customers’ and patients’ expectations.

These two days in Lyon- France 🇫🇷 were also a great opportunity to meet old friends and to make new ones.

#pfecolleague #Logipharma2024 #leveragingdiversities #humancapitol

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs